HGF and neoplasm: Previous studies have reported that blocking VEGF/VEGFRs signaling may lead to hypoxia in the tumor microenvironment by inhibiting angiogenesis, resulting in activation of HGF/MET axis, which conferred drug resistance and increased local invasion and distant metastasis [43, 44].